Preclinical and early clinical studies of a novel compound SYHA1813 that efficiently crosses the blood–brain barrier and exhibits potent activity against glioblastoma - Concepedia

Concepedia

Publication | Open Access

Preclinical and early clinical studies of a novel compound SYHA1813 that efficiently crosses the blood–brain barrier and exhibits potent activity against glioblastoma

DOI Full Paper Access

17

Citations

28

References

2023

Year

Yingqiang Liu, Zhengsheng Zhan, Zhuang Kang, Mengyuan Li, Yongcong Lv, Shenglan Li, Linjiang Tong, Feng Fang, Yan Li, Mengge Zhang,

Acta Pharmaceutica Sinica B

References

	Year	Citations

Page 1